ATRX KO induces ALT activation in the telomerase-negative cancer cells but, alone, is not sufficient to activate ALT in telomerase-positive cancer cells, in which it was necessary to also create gene KO of TERT through the CRISPR-Cas9 system to achieve comparable results [53]. This evidence concerns the gene TERT and cancer.